Market open
Cronos Group/$CRON
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Cronos Group
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
Ticker
$CRON
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Toronto, Canada
Employees
356
Website
Cronos Group Metrics
BasicAdvanced
$728M
-
-$0.12
1.02
-
Price and volume
Market cap
$728M
Beta
1.02
52-week high
$3.14
52-week low
$1.86
Average daily volume
1.4M
Financial strength
Current ratio
24.244
Quick ratio
22.632
Long term debt to equity
0.077
Total debt to equity
0.164
Management effectiveness
Return on assets (TTM)
-3.14%
Return on equity (TTM)
-4.37%
Valuation
Price to revenue (TTM)
6.521
Price to book
0.96
Price to tangible book (TTM)
1
Price to free cash flow (TTM)
43.435
Growth
Revenue change (TTM)
30.31%
Earnings per share change (TTM)
-56.68%
3-year revenue growth (CAGR)
19.19%
3-year earnings per share growth (CAGR)
-50.43%
What the Analysts think about Cronos Group
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Cronos Group stock.
Cronos Group Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Cronos Group Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Cronos Group News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Cronos Group stock?
Cronos Group (CRON) has a market cap of $728M as of January 27, 2025.
What is the P/E ratio for Cronos Group stock?
The price to earnings (P/E) ratio for Cronos Group (CRON) stock is 0 as of January 27, 2025.
Does Cronos Group stock pay dividends?
No, Cronos Group (CRON) stock does not pay dividends to its shareholders as of January 27, 2025.
When is the next Cronos Group dividend payment date?
Cronos Group (CRON) stock does not pay dividends to its shareholders.
What is the beta indicator for Cronos Group?
Cronos Group (CRON) has a beta rating of 1.02. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.